Column Capital Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$517K Sell
1,187
-5
-0.4% -$2.27K 0.08% 83
2023
Q2
$530K Sell
1,192
-203
-15% -$93.6K 0.07% 82
2023
Q1
$642K Buy
1,395
+483
+53% +$230K 0.1% 69
2022
Q4
$468K Buy
912
+44
+5% +$22.3K 0.08% 73
2022
Q3
$394K Sell
868
-48
-5% -$23K 0.08% 69
2022
Q2
$442K Buy
916
+1
+0.1% +$495 0.08% 65
2022
Q1
$450K Buy
915
+71
+8% +$32.5K 0.08% 72
2021
Q4
$391K Buy
844
+4
+0.5% +$1.68K 0.08% 84
2021
Q3
$313K Sell
840
-21
-2% -$7.98K 0.07% 91
2021
Q2
$329K Hold
861
0.07% 81
2021
Q1
$309K Hold
861
0.07% 84
2020
Q4
$276K Sell
861
-71
-8% -$21.8K 0.07% 86
2020
Q3
$251K Hold
932
0.08% 76
2020
Q2
$245K Buy
932
+19
+2% +$5.07K 0.08% 75
2020
Q1
$207K Buy
913
+54
+6% +$14.7K 0.08% 70
2019
Q4
$259K Buy
+859
New +$236K 0.13% 70

Other funds holding ELV